Capital World Investors’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Capital World Investors’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-587,300	Closed	-$29.5M	–	557
2015 Q1	$29.5M	Buy	587,300 +40,000	+7%	+$1.68M	0.01%	413
2014 Q4	$19M	Hold	547,300	–	–	0.01%	444
2014 Q3	$17.9M	Hold	547,300	–	–	0.01%	441
2014 Q2	$21M	Hold	547,300	–	–	0.01%	425
2014 Q1	$21.8M	Buy	547,300 +47,000	+9%	+$2.1M	0.01%	417
2013 Q4	$18.6M	Buy	500,300 +175,300	+54%	+$7.27M	0.01%	421
2013 Q3	$14.9M	Hold	325,000	–	–	﹤0.01%	428
2013 Q2	$8.79M	Buy	+325,000	New	+$7.44M	﹤0.01%	442

Other funds holding KYTH

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Capital World Investors's KYTH Position: Q2 2015 in Review

Capital World Investors sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q2 2015, closing a stake of 587,300 shares — an estimated $29.5M sold.

Capital World Investors first reported a position in KYTH in Q2 2013 and held it in 8 quarters. The position peaked at $29.5M in Q1 2015. 153 funds tracked by Wall St. Rank hold KYTH as of Q2 2015.

Capital World Investors reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q2 2015 after selling out during the quarter.
Capital World Investors sold 587,300 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q2 2015, an estimated $29.5M.
Capital World Investors first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 8 quarters.
Capital World Investors's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $29.5M in Q1 2015.
153 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q2 2015.

Based on Capital World Investors's 13F filing for Q2 2015, filed 14 Aug 2015.